Cargando…

2-Deoxy-d-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells

Tumor cells display a shift in energy metabolism from oxidative phosphorylation to aerobic glycolysis. A subset of papillary thyroid carcinoma (PTC) is refractory to surgery and radioactive iodine ablation. Doxorubicin and sorafenib are the drugs of choice for treating advanced thyroid cancer but bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shuo-Yu, Wei, Yau-Huei, Shieh, Dar-Bin, Lin, Li-Ling, Cheng, Shih-Ping, Wang, Pei-Wen, Chuang, Jiin-Haur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489888/ https://www.ncbi.nlm.nih.gov/pubmed/26134286 http://dx.doi.org/10.1371/journal.pone.0130959

Ejemplares similares

MDA5 complements TLR3 in suppression of neuroblastoma
por: Hsu, Wen-Ming, et al.
Publicado: (2015)

Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer
por: Danilovic, Debora L. S., et al.
Publicado: (2018)

Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?
por: Shing, Kit, et al.
Publicado: (2020)

Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo
por: Liu, Jia, et al.
Publicado: (2022)

Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma
por: Kim, Seok-Mo, et al.
Publicado: (2022)

Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib
por: Hussain, Syed Zubair, et al.
Publicado: (2013)

Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma
por: Chang, Hang-Seok, et al.
Publicado: (2023)

Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma
por: Wang, Yichao, et al.
Publicado: (2021)

Accelerated Disease Progression after Discontinuation of Sorafenib in a Patient with Metastatic Papillary Thyroid Cancer
por: Yun, Kyung-Jin, et al.
Publicado: (2014)

Non-radioactive 2-deoxy-2-fluoro-D-glucose inhibits glucose uptake in xenograft tumours and sensitizes HeLa cells to doxorubicin in vitro
por: Niccoli, Sarah, et al.
Publicado: (2017)

Antiangiogenic Activity of 2-Deoxy-D-Glucose
por: Merchan, Jaime R., et al.
Publicado: (2010)

Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer
por: Kim, Yuna, et al.
Publicado: (2023)

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
por: El Dika, Imane, et al.
Publicado: (2020)

2-Deoxy-D-glucose and combined 2-Deoxy-D-glucose/albendazole exhibit therapeutic efficacy against Echinococcus granulosus protoscoleces and experimental alveolar echinococcosis
por: Xin, Qi, et al.
Publicado: (2022)

Hand-foot syndrome associated with use of sorafenib in a patient with papillary thyroid cancer: a case report
por: Velandia-Carrillo, Carlos, et al.
Publicado: (2014)

Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
por: Takinami, Masaki, et al.
Publicado: (2020)

HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression
por: Song, Hongjun, et al.
Publicado: (2023)

Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study
por: Yihao, Liu, et al.
Publicado: (2022)

Macrophage Inflammatory Protein-1 Alpha, a Potential Biomarker for Predicting Left Atrial Remodeling in Patients With Atrial Fibrillation
por: Chen, Yung-Lung, et al.
Publicado: (2021)

2-deoxy-d-glucose Ameliorates Animal Models of Dermatitis
por: Choi, Soo Young, et al.
Publicado: (2020)

Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose
por: Penna, Patricia Sola, et al.
Publicado: (2023)

Computerized Cytological Features for Papillary Thyroid Cancer Diagnosis—Preliminary Report
por: Shih, Shyang-Rong, et al.
Publicado: (2019)

Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report
por: Higuchi, Yousuke, et al.
Publicado: (2017)

Immunohistochemistry Helps to Distinguish Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features/Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma with Other Follicular Thyroid Lesions
por: Chuang, Hao-Wen, et al.
Publicado: (2021)

Transport of deoxy-d-glucose into lymphocytes of patients with polycystic ovary syndrome
por: Oleszczak, Bożenna, et al.
Publicado: (2014)

2-Deoxy-2-fluoro-d-glucose metabolism in Arabidopsis thaliana
por: Fatangare, Amol, et al.
Publicado: (2015)

2 deoxy-D-glucose augments the mitochondrial respiratory chain in heart
por: Aiestaran-Zelaia, Irati, et al.
Publicado: (2022)

Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery
por: Babos, György, et al.
Publicado: (2020)

Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines
por: Yang, Ya-Ting, et al.
Publicado: (2022)

Sorafenib in Metastatic Papillary Thyroid Carcinoma with BRAF K601E Mutation on Liquid Biopsy: A Case Report and Literature Review
por: Caterino, Marianna, et al.
Publicado: (2022)

Selective use of sorafenib in the treatment of thyroid cancer
por: Pitoia, Fabián, et al.
Publicado: (2016)

Expression Patterns of Glucose Transporter-1 Gene and Thyroid Specific Genes in Human Papillary Thyroid Carcinoma
por: Kim, Sungeun, et al.
Publicado: (2014)

Endotoxin and CD14 in the progression of biliary atresia
por: Chou, Ming-Huei, et al.
Publicado: (2010)

Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-d-glucose uptake in human adipocytes
por: Stuart Wood, I., et al.
Publicado: (2007)

Treatment for papillary thyroid microcarcinoma
por: Shi, Lan, et al.
Publicado: (2013)

2‐Deoxy‐D‐glucose impedes T cell–induced apoptosis of keratinocytes in oral lichen planus
por: Wang, Fang, et al.
Publicado: (2021)

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
por: Dwojak, M, et al.
Publicado: (2015)

5-aza-2′-Deoxycytidine Induces a RIG-I-Related Innate Immune Response by Modulating Mitochondria Stress in Neuroblastoma
por: Lin, Hung-Yu, et al.
Publicado: (2020)

ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN
por: Wu, Jian-Ching, et al.
Publicado: (2023)

Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma Cells
por: Xiong, Qingqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5g50gfm0p5dautk96g4d5fmhfb